Ampio Pharmaceuticals was a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options.
It closed its doors on August 16, 2024
Company Details
- Employees
- 7
- Address
- 373 Inverness Pkwy,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://ampiopharma.com
- HQ
- Englewood, Colorado
Ampio Pharmaceuticals, Inc. Questions
Ampio Pharmaceuticals, Inc.'s website is http://ampiopharma.com
Ampio Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/ampiopharma
Ampio Pharmaceuticals, Inc. has
7 employees.
View email and phone details for 7
employees at Ampio Pharmaceuticals, Inc..
Ampio Pharmaceuticals, Inc.'s industry is
Pharmaceutical Manufacturing
Ampio Pharmaceuticals, Inc.'s top competitors are
Rumpus Therapeutics,
Reven Pharmaceuticals,
Zynex Medical,
Nexien Biopharma,
B&b Pharmaceuticals, Inc.,
Neos Therapeutics, Inc.,
Pharma Source Direct,
Leiters Health,
Xeris Pharmaceuticals, Inc.,
Aytu Biopharma.
Ampio Pharmaceuticals, Inc.'s categories are Pharmaceutical Manufacturing
